113 related articles for article (PubMed ID: 37022021)
1. Synergistic Effects of Radiotherapy With JNK Inhibitor-Incorporated Nanoparticle in an Intracranial Lewis Lung Carcinoma Mouse Models.
Li CH; Lim SH; Jeong YI; Ryu HH; Jung S
IEEE Trans Nanobioscience; 2023 Oct; 22(4):845-854. PubMed ID: 37022021
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Radiotherapeutic Effect With Nanoparticle-Mediated Radiosensitizer Delivery Guided By Focused Gamma Rays In Lewis Lung Carcinoma-Bearing Mouse Brain Tumor Models.
Lim SH; Li CH; Jeong YI; Jang WY; Choi JM; Jung S
Int J Nanomedicine; 2019; 14():8861-8874. PubMed ID: 32009784
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of radiosensitivity by inhibition of c-Jun N-terminal kinase activity in a Lewis lung carcinoma‑bearing subcutaneous tumor mouse model.
Li CH; Lim SH; Ryu HH; Moon KS; Jung TY; Jung S
Oncol Rep; 2016 Dec; 36(6):3397-3404. PubMed ID: 27779695
[TBL] [Abstract][Full Text] [Related]
4. Growth suppression of human mast cells expressing constitutively active c-kit receptors by JNK inhibitor SP600125.
Wang B; Tsukada J; Higashi T; Mizobe T; Matsuura A; Mouri F; Sawamukai N; Ra C; Tanaka Y
Genes Cells; 2006 Sep; 11(9):983-92. PubMed ID: 16923120
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal injection of JNK-specific inhibitor SP600125 inhibits the expression of presenilin-1 and Notch signaling in mouse brain without induction of apoptosis.
Rahman M; Zhang Z; Mody AA; Su DM; Das HK
Brain Res; 2012 Apr; 1448():117-28. PubMed ID: 22353755
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of sorafenib-incorporated nanoparticles of dextran/poly(dl-lactide-co-glycolide) block copolymer.
Kim DH; Kim MD; Choi CW; Chung CW; Ha SH; Kim CH; Shim YH; Jeong YI; Kang DH
Nanoscale Res Lett; 2012 Jan; 7(1):91. PubMed ID: 22283905
[TBL] [Abstract][Full Text] [Related]
7. 2-methoxyestradiol, an endogenous mammalian metabolite, radiosensitizes colon carcinoma cells through c-Jun NH2-terminal kinase activation.
Zou H; Adachi M; Imai K; Hareyama M; Yoshioka K; Zhao S; Shinomura Y
Clin Cancer Res; 2006 Nov; 12(21):6532-9. PubMed ID: 17085668
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent.
Du L; Lyle CS; Obey TB; Gaarde WA; Muir JA; Bennett BL; Chambers TC
J Biol Chem; 2004 Mar; 279(12):11957-66. PubMed ID: 14704147
[TBL] [Abstract][Full Text] [Related]
9. MAPK regulation and caspase activation are required in DMNQ S-52 induced apoptosis in Lewis lung carcinoma cells.
Lee SJ; Sakurai H; Koizumi K; Song GY; Bae YS; Kim HM; Kang KS; Surh YJ; Saiki I; Kim SH
Cancer Lett; 2006 Feb; 233(1):57-67. PubMed ID: 15893420
[TBL] [Abstract][Full Text] [Related]
10. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
Ikeda F; Matsubara T; Tsurukai T; Hata K; Nishimura R; Yoneda T
J Bone Miner Res; 2008 Jun; 23(6):907-14. PubMed ID: 18251700
[TBL] [Abstract][Full Text] [Related]
11. An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins.
Takamura M; Matsuda Y; Yamagiwa S; Tamura Y; Honda Y; Suzuki K; Ichida T; Aoyagi Y
Life Sci; 2007 Mar; 80(14):1335-44. PubMed ID: 17300814
[TBL] [Abstract][Full Text] [Related]
12. Synergetic and Antagonistic Molecular Effects Mediated by the Feedback Loop of p53 and JNK between Saikosaponin D and SP600125 on Lung Cancer A549 Cells.
Chen X; Liu C; Zhao R; Zhao P; Wu J; Zhou N; Ying M
Mol Pharm; 2018 Nov; 15(11):4974-4984. PubMed ID: 30207732
[TBL] [Abstract][Full Text] [Related]
13. c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells.
Vivo C; Liu W; Broaddus VC
J Biol Chem; 2003 Jul; 278(28):25461-7. PubMed ID: 12707267
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of c-Jun N-terminal kinase prevents blood-brain barrier disruption and normalizes the expression of tight junction proteins clautin-5 and ZO-1 in a rat model of subarachnoid hemorrhage.
Chen D; Wei XT; Guan JH; Yuan JW; Peng YT; Song L; Liu YH
Acta Neurochir (Wien); 2012 Aug; 154(8):1469-76; discussion 1476. PubMed ID: 22661329
[TBL] [Abstract][Full Text] [Related]
15. Differential requirement for c-Jun NH2-terminal kinase in TNFalpha- and Fas-mediated apoptosis in hepatocytes.
Schwabe RF; Uchinami H; Qian T; Bennett BL; Lemasters JJ; Brenner DA
FASEB J; 2004 Apr; 18(6):720-2. PubMed ID: 14766793
[TBL] [Abstract][Full Text] [Related]
16. [Protective effects and mechanism of SP600125 on lung ischemia/reperfusion injury in rats].
Qiu XX; Dai YY; Song ZJ; Fang ZX; Wang WT
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 May; 28(3):255-8. PubMed ID: 22860429
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor growth, angiogenesis, and tumor cell proliferation by a small molecule inhibitor of c-Jun N-terminal kinase.
Ennis BW; Fultz KE; Smith KA; Westwick JK; Zhu D; Boluro-Ajayi M; Bilter GK; Stein B
J Pharmacol Exp Ther; 2005 Apr; 313(1):325-32. PubMed ID: 15626722
[TBL] [Abstract][Full Text] [Related]
18. Costunolide-induced apoptosis in human leukemia cells: involvement of c-jun N-terminal kinase activation.
Choi JH; Lee KT
Biol Pharm Bull; 2009 Oct; 32(10):1803-8. PubMed ID: 19801848
[TBL] [Abstract][Full Text] [Related]
19. Myocardial protective effects of a c-Jun N-terminal kinase inhibitor in rats with brain death.
Guo W; Cao S; Yan B; Zhang G; Li J; Zhao Y; Zhang S
J Cell Mol Med; 2016 Jul; 20(7):1214-8. PubMed ID: 27072084
[TBL] [Abstract][Full Text] [Related]
20. IKappaB-kinase/nuclear factor-kappaB signaling prevents thermal injury-induced gut damage by inhibiting c-Jun NH2-terminal kinase activation.
Chen LW; Chen PH; Chang WJ; Wang JS; Karin M; Hsu CM
Crit Care Med; 2007 May; 35(5):1332-40. PubMed ID: 17414734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
